J Safra Sarasin impact fund invests in vaccines, recycling

J Safra Sarasin's recently-launched €25 million ($29 million) impact fund has invested in a biotechnology company and a company involved in the recycling of hazardous waste.

To access this article please sign-in below or register for a free one-month trial.

Forgot your password?

To access the premium content on Environmental Finance, you must first sign in to your account

Not registered? Take a free no obligation one-month trial.

Register for a trial